Clinical Trials Browser

Recurrence × codrituzumab × 90 days × Clear all

NCT04928677 2026-02-17

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Phase 1 Recruiting

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Recurrence, Hepatoblastoma